Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Augmentation in Bulimia Nervosa
NCT00988481Phase 4Withdrawn
- Sponsor
- Neuropsychiatric Research Institute
- Start
- Sep 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of topiramate in bulimia nervosa (BN), sponsored by Neuropsychiatric Research Institute. Primary endpoint: Weekly number of binge eating episodes and purging episodes. Planned start Sep 2009; status: withdrawn.
02
Drugs
topiramate
03
Conditions
bulimia nervosa (BN)
Beyond the preview
Go deeper on NCT00988481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988481.